Synthesis and preclinical evaluation of [methylpiperazine-C-11]brigatinib as a PET imaging agent for mutated EGFR and ALK positive tumors

Antonia Hognasbacka, Esther Kooijman, Robert Schuit, Maxime Schreurs, Mariska Verlaan, Wissam Beaino, Danielle Vugts, Guus van Dongen, Alex Poot, Albert Windhorst

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)S51-S52
JournalNuclear medicine and biology
Volume96-97
Publication statusPublished - 2021

Cite this